Amlodipine to protect kidneys after contrast dye
Treatments studied
Part of Heart & circulation, Kidney & urinary clinical trials.
This trial tests if amlodipine, a blood pressure medication, can help protect the kidneys from damage caused by contrast dye used in imaging tests. Participation may help reduce the risk of kidney injury after a contrast procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have diabetes.
- Your kidney function is normal (serum creatinine less than 1.2).
- You do not have high blood pressure.
- You are not bedridden or unable to take food or drink by mouth (NPO).
- You do not have chronic kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.
This trial compares drinking fluids by mouth versus receiving fluids through an IV to prevent kidney injury from CT contrast dye. It may be a good option if you have mild to moderate kidney disease and need a contrast CT while in the emergency department.
This study compares giving fluids through a vein versus drinking fluids to lower the risk of sudden kidney injury after a CT scan with contrast dye. It focuses on adults with very poor kidney function who are scheduled for an elective CT scan.
This trial tests whether a simple inorganic nitrate pill can protect your kidneys from damage caused by contrast dye used in heart catheterization or CT scans. It is for people whose kidneys are already somewhat weak, making them at higher risk for this type of injury.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
This study tests whether giving extra fluids by mouth before and during a common heart procedure (primary angioplasty) can reduce the risk of kidney damage caused by the contrast dye used during the procedure. If you have had a heart attack and are scheduled for this procedure, this trial may help protect your kidneys.
Hear when a new Contrast-induced Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.